Genetic Markers in Lung Cancer Diagnosis: A Review

Genetic Markers in Lung Cancer Diagnosis: A Review

Lung cancer is the most often diagnosed cancer in the world and the most frequent cause of cancer death. The prognosis for lung cancer is relatively poor and 75% of patients are diagnosed at its advanced stage. The currently used diagnostic tools are not sensitive enough and do not enable diagnosis...

Full description

Bibliographic Details
Main Authors:	Katarzyna Wadowska, Iwona Bil-Lula, Łukasz Trembecki, Mariola Śliwińska-Mossoń
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	International Journal of Molecular Sciences
Subjects:	lung cancer carcinogenesis genetic markers epigenetic markers liquid biopsy NGS
Online Access:	https://www.mdpi.com/1422-0067/21/13/4569

Similar Items

Markers Useful in Monitoring Radiation-Induced Lung Injury in Lung Cancer Patients: A Review
by: Mariola Śliwińska-Mossoń, et al.
Published: (2020-07-01)

New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma
by: Katarzyna Wadowska, et al.
Published: (2021-08-01)

Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients
by: Katarzyna Wadowska, et al.
Published: (2022-12-01)

A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
by: Paulina Nowak, et al.
Published: (2023-07-01)

Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis
by: Amro M. Soliman, et al.
Published: (2021-07-01)

The Use of DArTseq Technology to Identify New SNP and SilicoDArT Markers Related to the Yield-Related Traits Components in Maize
by: Agnieszka Tomkowiak, et al.
Published: (2022-05-01)

Is Cell-Free DNA Testing in Pancreatic Ductal Adenocarcinoma Ready for Prime Time?
by: Ankur Sheel, et al.
Published: (2022-07-01)

Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach
by: Paul Hofman
Published: (2023-09-01)

Associative and Physical Mapping of Markers Related to <i>Fusarium</i> in Maize Resistance, Obtained by Next-Generation Sequencing (NGS)
by: Aleksandra Sobiech, et al.
Published: (2022-05-01)

Analysis of <i>MMP-2</i>-735C/T (rs2285053) and <i>MMP-9</i>-1562C/T (rs3918242) Polymorphisms in the Risk Assessment of Developing Lung Cancer
by: Katarzyna Wadowska, et al.
Published: (2023-06-01)

Biochemical Markers of Saliva in Lung Cancer: Diagnostic and Prognostic Perspectives
by: Lyudmila V. Bel’skaya, et al.
Published: (2020-03-01)

The Cause and Effect Relationship of Diabetes after Acute Pancreatitis
by: Mariola Śliwińska-Mossoń, et al.
Published: (2023-02-01)

The Relevance of Gender in Tumor-Influencing Epigenetic Traits
by: Victoria Sarne, et al.
Published: (2019-01-01)

Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients
by: Kicman A, et al.
Published: (2022-11-01)

Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity
by: Lodovica Zullo, et al.
Published: (2023-12-01)

Liquid biopsy in non-small cell lung cancer: a meta-analysis of state-of-the-art and future perspectives
by: Sara Franzi, et al.
Published: (2023-12-01)

DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients
by: Lukas Vrba, et al.
Published: (2020-04-01)

Molecular markers for characterization and conservation of plant genetic resources
by: AEJAZ AHMAD DAR, et al.
Published: (2019-11-01)

BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01)

ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach
by: Lærke Rosenlund Nielsen, et al.
Published: (2024-01-01)

Dual NGS Comparative Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Non-Small Cell Lung Carcinoma (NSCLC)
by: Laura Buburuzan, et al.
Published: (2022-12-01)

The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment
by: Mohammad Hadi Abbasian, et al.
Published: (2022-10-01)

Monitoring EGFR-lung cancer evolution: a possible beginning of a “methylation era” in TKI resistance prediction
by: Federico Pio Fabrizio, et al.
Published: (2023-04-01)

Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?
by: Begoña O. Alen, et al.
Published: (2022-07-01)

Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2024-03-01)

Molecular Markers: A New Paradigm in the Prediction of Sperm Freezability
by: Michal Ďuračka, et al.
Published: (2023-02-01)

A modern look at the molecular-biological mechanisms of breast tumours in dogs
by: D. D. Bilyi, et al.
Published: (2020-03-01)

Consensus on Postoperative Recurrence Prediction of Non-small Cell Lung Cancer  Based on Molecular Markers
by: Guangdong Association of Thoracic Diseases
Published: (2022-10-01)

Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in <i>EGFR</i>-Mutated NSCLC
by: Martin P. Barr, et al.
Published: (2022-09-01)

Identification and Analysis of Candidate Genes Associated with Maize Fusarium Cob Resistance Using Next-Generation Sequencing Technology
by: Aleksandra Sobiech, et al.
Published: (2023-11-01)

G Protein-Coupled Receptor Genes, PTGDR1, PTGDR2, and PTGIR, Are Candidate Epigenetic Biomarkers and Predictors for Treated Patients with HPV-Associated Oropharyngeal Cancer
by: Kiyoshi Misawa, et al.
Published: (2020-09-01)

Results of liquid biopsy studies by next generation sequencing in patients with advanced stage non-small cell lung cancer: Single center experience from Turkey
by: Buyuksimsek M, et al.
Published: (2019-12-01)

Bibliometric and visualized analysis of applying tumor markers in lung cancer diagnosis from 2000 to 2022
by: Shi‐Peng Ke, et al.
Published: (2023-08-01)

Advancements in the Diagnosis of Hepatocellular Carcinoma
by: Natalia Salinas Parra, et al.
Published: (2023-01-01)

Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines
by: Victoria Sarne, et al.
Published: (2020-06-01)

Development of SNP Marker Sets for Marker-Assisted Background Selection in Cultivated Cucumber Varieties
by: Eun Su Lee, et al.
Published: (2022-02-01)

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)
by: Silvia Salmoiraghi, et al.
Published: (2020-08-01)

Cardioprotective Effect of Acetylsalicylic Acid in the Myocardial Ischemia-Reperfusion Model on Oxidative Stress Markers Levels in Heart Muscle and Serum
by: Piotr Frydrychowski, et al.
Published: (2022-07-01)

Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows
by: Marco Montella, et al.
Published: (2022-11-01)

Oligo-Metastatic Disease in Oncology: Exploring the Limits and the Potential of Genetic Assessment
by: Mariachiara Santorsola, et al.
Published: (2023-11-01)